HearingAssist Eaze vs ReSound OMNIA miniRIE
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

HearingAssist Eaze
The HearingAssist Eaze is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.4/5 in our lab testing. At $399, it positions itself as an affordable behind-the-ear option in the crowded OTC market, ranking #43 of 65 OTC hearing aids tested. In our testing, the Eaze showed mixed results across performance categories. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling during typical daily activities. However, speech performance is a weakness: speech in quiet scored 2.6/5 (0.20 points below average) and speech in noise scored just 1.3/5 (also 0.20 points below average), which may limit benefit in challenging listening environments. The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average of 1.92/5. Consumers who prioritize streaming audio from their phones should consider alternatives. Own-voice comfort also scored below average at 2.2/5, which may affect how natural users sound to themselves. At this price point, buyers have several higher-scoring alternatives to consider, including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5). The Eaze may suit budget-conscious consumers who prioritize feedback-free wear over streaming capability and don't frequently encounter noisy environments.
Choice

ReSound OMNIA miniRIE
The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit